Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Chf Solutions Inc (CHFS)

Chf Solutions Inc (CHFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,759
  • Shares Outstanding, K 2,268
  • Annual Sales, $ 5,000 K
  • Annual Income, $ -17,030 K
  • 60-Month Beta 2.47
  • Price/Sales 1.42
  • Price/Cash Flow N/A
  • Price/Book 0.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -13.03
  • Growth Rate Est. (year over year) +7,766.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.86 +4.20%
on 06/07/19
3.50 -14.86%
on 06/13/19
-0.39 (-11.57%)
since 05/24/19
3-Month
2.86 +4.20%
on 06/07/19
4.89 -39.06%
on 04/02/19
-0.74 (-19.89%)
since 03/26/19
52-Week
2.86 +4.20%
on 06/07/19
33.74 -91.17%
on 06/27/18
-30.62 (-91.13%)
since 06/26/18

Most Recent Stories

More News
CHF Solutions To Exhibit At the American Association of Heart Failure Nurses 15th Annual Meeting

CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 15 Annual Meeting of the American Association of Heart Failure Nurses (AAHFN) June 27-29, 2019 at the JW Marriott Austin in Austin,...

CHFS : 2.98 (-4.49%)
CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow(R) System at Beebe Healthcare

CHF Solutions (Nasdaq: CHFS) today announces that Sussex County, Delaware-based health system, Beebe Healthcare, has initiated offering ultrafiltration therapy using the company's Aquadex FlexFlow system....

CHFS : 2.98 (-4.49%)
CHF Solutions, Inc. Announces 17 Percent Increase in Revenues for First Quarter 2019 Over Previous Year and Provides Company Update

CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the first quarter ended March 31, 2019, which included the following highlights:

CHFS : 2.98 (-4.49%)
CHF Solutions Welcomes Industry Veteran Nestor Jaramillo as Chief Commercial Officer

CHF Solutions (Nasdaq: CHFS) today announces it has hired Nestor Jaramillo, Jr. as its new chief commercial officer, effective May 7, 2019.

CHFS : 2.98 (-4.49%)
CHF Solutions, Inc. To Announce First Quarter 2019 Financial Results on May 7, 2019

CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its first quarter 2019 financial results will be released on Tuesday, May 7, 2019. The company will host a conference call and webcast at 9:00 AM...

CHFS : 2.98 (-4.49%)
CHF Solutions to Sponsor CT Theatre Session, "Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies" Moderated by Renowned Cardiothoracic Surgeon Daniel Beckles, M.D., Ph.D., at the 2019 AATS Annual Meeting

CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a CT Theatre Session at the American Association for Thoracic Surgery Annual Meeting on Monday, May 6, 2019, 1:00-1:30 pm at the Metro...

CHFS : 2.98 (-4.49%)
CHF Solutions Announces Launch of Ultrafiltration Program at Heart Hospital at Saint Francis

CHF Solutions (Nasdaq: CHFS) today announced that Heart Hospital at Saint Francis has launched an ultrafiltration program using the Aquadex FlexFlow(R) system to assist in the management of fluid overload...

CHFS : 2.98 (-4.49%)
CHF Solutions Announces Launch of Ultrafiltration Program at Oklahoma Heart Institute

CHF Solutions (Nasdaq: CHFS) today announced that Oklahoma Heart Institute in Tulsa, Oklahoma, has launched an ultrafiltration program using the Aquadex FlexFlow(R) system to assist in the management of...

CHFS : 2.98 (-4.49%)
CHF Solutions Submits Patent Application for Pediatric Use of Aquadex FlexFlow(R) System

CHF Solutions (Nasdaq: CHFS) today announced the submission of a method of use application to the United States Patent and Trademark Administration for pediatric use of its Aquadex Flex Flow System.

CHFS : 2.98 (-4.49%)
CHF Solutions to Exhibit at The International Society for Heart and Lung Transplantation 2019 Annual Meeting and Scientific Sessions

CHF Solutions (Nasdaq: CHFS), today announced it will be exhibiting at the 2019 Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) on April 3-6,...

CHFS : 2.98 (-4.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade CHFS with:

Business Summary

CHF Solutions, Inc. is a medical device company which focused on commercializing the Aquadex FlexFlow (R) System. Its commercial product Aquadex system, is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended ultrafiltration treatment...

See More

Key Turning Points

2nd Resistance Point 3.22
1st Resistance Point 3.10
Last Price 2.98
1st Support Level 2.88
2nd Support Level 2.79

See More

52-Week High 33.74
Fibonacci 61.8% 21.94
Fibonacci 50% 18.30
Fibonacci 38.2% 14.66
Last Price 2.98
52-Week Low 2.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar